SeraCare logo — LGC Clinical Diagnostics | Science for a Safer World

SeraCare

LGC Clinical Diagnostics | Science for a Safer World

Founded 1984 United States Milford, United States 111 employees Private Equity Biotechnology, Health Care +1

General Information

Company Name SeraCare
Founded Year 1984
Location United States Milford, United States
Employees 111
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Private Equity
Business Model B2B, E Commerce, D2C
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with SeraCare. To contact SeraCare, visit seracare.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SeraCare compare?

A PDF of SeraCare and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SeraCare soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SeraCare

SeraCare, a pioneering entity within LGC's Clinical Diagnostics Division, exemplifies impactful innovation in the field of precision medicine. Established in 1984, the company is headquartered in the United States and operates at the intersection of Biotechnology, Health Care, and Pharmaceutical industries.

Under the guiding principle of their slogan, "LGC Clinical Diagnostics | Science for a Safer World", SeraCare provides advanced tools and technologies that not only enhance the diagnostic process but also set standards for regulating precision diagnostics. Their diverse product portfolio includes quality control technologies and disease-state specimens, offering robust solutions for research and development.

The absence of recent funding details might suggest stable internal revenue generation, yet it signals potential growth opportunities for investors looking to support innovation in diagnostics. With a legacy spanning decades, SeraCare stands as a reliable player capable of driving advancements in sector-specific technologies and health outcomes.

Business keywords: Precision Medicine, Diagnostic Assays, Quality Control Technologies, Disease-State Specimens, Immunoassay Reagents, Diagnostic Controls, Plasma-Derived Reagents, Molecular Biomarkers, Bio Banking, Contract Research Services, Molecular Biology, Virology, Immunology, Biochemistry, NGS Reference Materials

Services & Products

Customizable Biological Materials
Quality Assurance in Assay Performance
Reference Materials for Diagnostics
EQA & Proficiency Panels

Target Customers

Diagnostic Assay Developers Clinical Laboratories Research Institutions Healthcare Providers

No funding data available for SeraCare yet.

SeraCare Alternatives & Competitors

View All Alternatives
SeraCare vs
Mindpeak
Mindpeak Germany

Our mission is to enable personalised cancer treatment through AI tissue diagnostics

Series A
53 employees
AI, Biotechnology
SeraCare vs

Revolutionizing Molecular Diagnostics with world-class Innovative IVD Solutions.

103 employees
Biotechnology, Health Care
SeraCare vs
Noscendo
Noscendo Germany

Innovation, precision, and purpose - redefining infection diagnostics for better outcomes.

37 employees
Biotechnology, Health Care

FAQ About SeraCare

LGC Clinical Diagnostics | Science for a Safer World
SeraCare was founded in 1984.
SeraCare is headquartered in Milford, United States.
SeraCare operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Precision Medicine, Diagnostic Assays, Quality Control Technologies and Disease-State Specimens. Its customers include Diagnostic Assay Developers, Clinical Laboratories and Research Institutions.
SeraCare has a B2B, E Commerce and D2C business model. Its revenue comes from Product Sales, Service Fee and Licensing.
SeraCare has approximately 111 employees.
SeraCare offers: Customizable Biological Materials, Quality Assurance in Assay Performance, Reference Materials for Diagnostics, EQA & Proficiency Panels.
Top alternatives and competitors to SeraCare include Mindpeak, G2M | Next Generation IVD solutions for Genomics, Noscendo, Onc.AI, Invivoscribe. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SeraCare and Mindpeak are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SeraCare, https://bouncewatch.com/company/seracare, updated 1 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes